Clinical trial

Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study

NCT02401269

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Mapped RxNorm record Aspirin Normalized identity: aspirinView linked drug · Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention Placebo Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Cardiovascular Risk in HIV Patients on Antiretroviral Therapy Therapy: The MHEART Study

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE1, PHASE2

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2015-04-01

PhasePHASE1 / PHASE2

Conditions

Cardiovascular Disease Risk in HIV Patientsunresolved

Endothelial Functionunresolved

Interventions

AspirinDRUG · verified · RxNorm: aspirin

PlaceboDRUG

Sponsors & collaborators

University of Pittsburghlead sponsor

Fogarty International Center of the National Institute of Healthcollaborator

University of North Carolinacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT02401269 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.